BIBLIOGRAFÍA

1.-    GREEN R, SCHUCHTER L. Paraneoplastic Syndromes. Best Practice of Medicine, July 1999. Available from: URL: http://merck.praxis.md/bmp/on/paraneo.

2.-    LUO J, HWANG S, WU J, LI C, HSIAO L, et al. Paraneoplastic Syndromes in patients with hepatocellular carcinoma in Taiwan. Cancer 1999; 86: 799-804.

3.-    MATSUYAMA M. Erythrocytosis caused by an erythropoeitin-producing hepatocellular carcinoma. J Surg Oncol 2000; 75: 197-2002.

4.-    NDUBUBA D, OJO O, ADETILOYE V, et al. The incidence and characteristics of some paraneoplastic sindromes of hepatocellular carcinoma in Nigerian patients. Eur J Gastroenterol Hepatol 1999; 11: 1401-4.

5.-    CHU C, HWANG S, LUO J, et al. Manifestations of hypercholesterolaemia, hypoglicemia, erythrocytosis and hypercalcemia in patients with hepatocellular carcinoma: report of two cases. J Gastroenterol Hepatol 1999; 14: 807-810.

6.-    HWANG S, LEE S, WU J, et al. Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma. [Abstract]. Zhonghua Yi Xue Za Zhi (Taipei) 1994; 53: 262-9.

7.-    SAKISAKA S, WATANABE M, TATEISHI H, et al. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: inmunohistochemical evidence, Hepatology 1993; 18: 1357-1362.

8.-    KEW M, FISHER J. Serum erythropoeitin concentrations in patients with hepatocellular carcinoma. Cancer 1986; 58: 2485-8.

9.-    GOLDE D, HOCKING W, KOEFFLER H, et al. Polycythemia: Mechanisms and management. UCLA Conference. Ann Int Med 1981; 95: 71-87.

10.-    FARUKI H, KISS J. Erythropoietin. Institute for Transfusion Medicine. Transfusion Medicine Update [serial on line]. 1995 July.

11.-    BESA E. Polycythemia secondary. Medicine Journal [serial on line] 2002 Jan; 3:1: [10 screens]. Available from: URL: http://www.emedicin.com/med/topic1863.htm.

12.-    DAINIAK N, KULKARNI V, HOWARD D, et al. Mechanisms of abdominal erythropoeisis in malignancy. Cancer 1983; 51: 1101-6.

REGRESAR AL ARTÍCULO